Recently, a number of studies have reported the presence of interleukin 17 (IL-17) in patients with Lyme disease, and several murine studies have suggested a role for this cytokine in the development of Lyme arthritis. However, the role of IL-17 has not been studied using the experimental Lyme borreliosis model of infection of C3H mice with Borrelia burgdorferi. In the current study, we investigated the role of IL-17 in the development of experimental Lyme borreliosis by infecting C3H mice devoid of the common IL-17 receptor A subunit (IL-17RA) and thus deficient in most IL-17 signaling. Infection of both C3H and C3H IL-17RA-/- mice led to the production of high levels of IL-17 in the serum, low levels in the heart tissue, and no detectable IL-17 in the joint tissue. The development and severity of arthritis and carditis in the C3H IL-17RA-/- mice were similar to what was seen in wildtype C3H mice. In addition, development of antiborrelia antibodies and clearance of spirochetes from tissues were similar for the two mouse strains. These results demonstrate a limited role for IL-17 signaling through IL-17RA in the development of disease following infection of C3H mice with B. burgdorferi.
CITATION STYLE
Lasky, C. E., Jamison, K. E., Sidelinger, D. R., Pratt, C. L., Zhang, G., & Brown, C. R. (2015). Infection of interleukin 17 receptor a-deficient C3H mice with Borrelia burgdorferi does not affect their development of Lyme arthritis and carditis. Infection and Immunity, 83(7), 2882–2888. https://doi.org/10.1128/IAI.00533-15
Mendeley helps you to discover research relevant for your work.